Gender matter! EUKON move on mission 5
Caserta, ITALY – August 8th, 2023 We are absolutely…
Caserta, ITALY – August 8th, 2023 We are absolutely…
FT 1000: the sixth annual list of Europe’s fastest-growing companies…
Leader della Crescita is rank of first 450 companies, done…
EUKON and SMT present Next Generation PCI Symposia at GISE…
EUKON SMT present Innovations in Structural Heart Intervention PFO and TAVI…
At EuroPCR 2021 TALENT 3yrs follow up has been presented.…
FAVOR III China has bees published on Lancet and simultaneously…
Dr Stefano Galli Interventional Cardiologist at “Cardiologico Monzino” in Milan…
Multicenter-clinical-evaluation-of-a-piezoresistive-MEMSsensor-rapid-exchange-pressure-microcatheter-system-for-fractional-flow-reserve-measurement-2021.pdf This multicenter, prospective clinical study investigates whether the…
11 March 2021 The PROSPECT II Study has been published…
In this interview Dr Simone Biscaglia, S. Anna University in…
Today dr Luigi di Serafino of University Federico II in…
The VULNERABLE PATIENT WHO is the vulnerable patient ? HOW…
Physiology-guided PCI in MVD Chairman Prof. Emanuele Barbato and Dr…
February 5th(Fri.) 9:00-11:10 am (C.E.T.) Insight Lifetech Co., Ltd We…
CollecTiOn Sharing Expertise through West and East Chairperson: Prof. Jianping…
For read click on The PROSPECT ABSORB Study (Jacc 2020)
The PROSPECT II study was presented as Late-Breaking Clinical Trials…
Click here to see where do we stand?
Watch video to discover how.
Caserta, ITALY – September 8th, 2021 — EUKON’ experience in…